In this study, we found that the downregulation of miR-522-3p expression was strongly associated with the acquisition of paclitaxel resistance in ovarian cancer cells, while the restoration of miR-522-3p attenuated paclitaxel resistance through the targeting of E2F2. This evidence concerns the gene E2F2 and ovarian carcinoma.